Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
101 | International Journal of Nanomedicine | journal | 1.306 Q1 | 179 | 491 | 1274 | 20697 | 6757 | 1259 | 4.97 | 42.15 | |
102 | Mutagenesis | journal | 1.304 Q1 | 102 | 56 | 274 | 2193 | 1026 | 269 | 2.98 | 39.16 | |
103 | Clinical Trials | journal | 1.302 Q1 | 74 | 84 | 281 | 2004 | 488 | 232 | 1.85 | 23.86 | |
104 | AAPS Journal | journal | 1.298 Q1 | 132 | 129 | 283 | 5015 | 1341 | 274 | 4.37 | 38.88 | |
105 | Journal of Analytical Toxicology | journal | 1.298 Q1 | 85 | 109 | 297 | 2587 | 910 | 284 | 3.21 | 23.73 | |
106 | Journal of managed care & specialty pharmacy | journal | 1.295 Q1 | 75 | 122 | 206 | 3932 | 526 | 152 | 2.55 | 32.23 | |
107 | NeuroToxicology | journal | 1.293 Q1 | 133 | 149 | 443 | 8236 | 1651 | 426 | 3.70 | 55.28 | |
108 | Progress in Medicinal Chemistry | journal | 1.293 Q1 | 38 | 5 | 17 | 534 | 61 | 1 | 3.27 | 106.80 | |
109 | Current Pharmaceutical Design | journal | 1.292 Q1 | 183 | 633 | 1649 | 76138 | 6048 | 1520 | 3.51 | 120.28 | |
110 | Current Medicinal Chemistry | journal | 1.282 Q1 | 202 | 322 | 1293 | 39596 | 5384 | 1224 | 4.11 | 122.97 | |
111 | Pharmaceutical Statistics | journal | 1.276 Q1 | 46 | 46 | 193 | 880 | 295 | 177 | 0.94 | 19.13 | |
112 | Reproductive Toxicology | journal | 1.274 Q1 | 129 | 141 | 418 | 6716 | 1576 | 389 | 3.63 | 47.63 | |
113 | Therapeutic Advances in Neurological Disorders | journal | 1.267 Q1 | 68 | 25 | 86 | 1144 | 356 | 83 | 3.88 | 45.76 | |
114 | Prostaglandins and Other Lipid Mediators | journal | 1.254 Q1 | 86 | 22 | 156 | 1069 | 436 | 151 | 2.48 | 48.59 | |
115 | Drug Metabolism and Disposition | journal | 1.252 Q1 | 194 | 243 | 820 | 10383 | 3137 | 813 | 3.71 | 42.73 | |
116 | Ecotoxicology | journal | 1.239 Q1 | 107 | 202 | 569 | 9990 | 1717 | 565 | 2.79 | 49.46 | |
117 | Nucleic Acid Therapeutics | journal | 1.239 Q1 | 77 | 43 | 154 | 2263 | 475 | 144 | 3.09 | 52.63 | |
118 | Drug Safety | journal | 1.238 Q1 | 140 | 95 | 321 | 4352 | 1058 | 282 | 3.30 | 45.81 | |
119 | ACS Medicinal Chemistry Letters | journal | 1.231 Q1 | 86 | 239 | 608 | 5933 | 1884 | 598 | 3.06 | 24.82 | |
120 | Toxicology | journal | 1.230 Q1 | 176 | 136 | 634 | 7352 | 2558 | 614 | 3.89 | 54.06 | |
121 | Cardiovascular Drugs and Therapy | journal | 1.222 Q1 | 79 | 70 | 211 | 2300 | 594 | 177 | 2.81 | 32.86 | |
122 | Current Neuropharmacology | journal | 1.212 Q1 | 103 | 44 | 177 | 5733 | 573 | 168 | 3.30 | 130.30 | |
123 | PharmacoEconomics | journal | 1.203 Q1 | 118 | 108 | 270 | 4933 | 708 | 232 | 2.49 | 45.68 | |
124 | Chemotherapy Research and Practice | journal | 1.202 Q1 | 5 | 3 | 1 | 139 | 4 | 1 | 0.00 | 46.33 | |
125 | European Journal of Clinical Pharmacology | journal | 1.198 Q1 | 123 | 183 | 666 | 6745 | 2109 | 569 | 3.15 | 36.86 | |
126 | Journal of Ethnopharmacology | journal | 1.196 Q1 | 231 | 688 | 2044 | 35654 | 7916 | 2031 | 3.63 | 51.82 | |
127 | Emerging Microbes and Infections | journal | 1.165 Q1 | 94 | 48 | 66 | 2923 | 155 | 60 | 2.35 | 60.90 | |
128 | Journal of Biomolecular Screening | journal | 1.155 Q1 | 86 | 140 | 386 | 4594 | 937 | 381 | 2.42 | 32.81 | |
129 | Expert Opinion on Drug Discovery | journal | 1.154 Q1 | 84 | 107 | 285 | 10590 | 1006 | 285 | 3.79 | 98.97 | |
130 | Current Topics in Medicinal Chemistry | journal | 1.149 Q1 | 133 | 234 | 703 | 18714 | 2544 | 624 | 3.31 | 79.97 | |
131 | Diabetes, Metabolic Syndrome and Obesity | journal | 1.149 Q1 | 64 | 60 | 108 | 3598 | 404 | 105 | 3.74 | 59.97 | |
132 | Pharmacology Biochemistry and Behavior | journal | 1.149 Q1 | 148 | 259 | 785 | 16888 | 2440 | 783 | 3.08 | 65.20 | |
133 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.142 Q1 | 47 | 40 | 55 | 2804 | 208 | 54 | 3.57 | 70.10 | |
134 | Toxicology Letters | journal | 1.142 Q1 | 163 | 362 | 898 | 16919 | 3428 | 879 | 3.58 | 46.74 | |
135 | Cancer Chemotherapy and Pharmacology | journal | 1.141 Q1 | 122 | 285 | 960 | 8854 | 3092 | 938 | 3.35 | 31.07 | |
136 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.137 Q1 | 82 | 15 | 38 | 2511 | 166 | 38 | 5.15 | 167.40 | |
137 | Human gene therapy methods | journal | 1.135 Q1 | 38 | 35 | 79 | 1603 | 209 | 79 | 2.65 | 45.80 | |
138 | Nanotechnology, Science and Applications | journal | 1.131 Q1 | 35 | 6 | 18 | 604 | 116 | 18 | 7.63 | 100.67 | |
139 | Future Medicinal Chemistry | journal | 1.114 Q1 | 90 | 171 | 563 | 11950 | 1507 | 450 | 2.43 | 69.88 | |
140 | ChemMedChem | journal | 1.110 Q1 | 119 | 320 | 688 | 12177 | 1932 | 668 | 2.76 | 38.05 | |
141 | Human Vaccines | journal | 1.110 Q1 | 63 | 0 | 264 | 0 | 736 | 199 | 0.00 | 0.00 | |
142 | Journal of Nanobiotechnology | journal | 1.109 Q1 | 109 | 59 | 153 | 2388 | 742 | 152 | 4.44 | 40.47 | |
143 | Investigational New Drugs | journal | 1.093 Q1 | 97 | 142 | 622 | 4435 | 2010 | 618 | 3.27 | 31.23 | |
144 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.092 Q1 | 52 | 22 | 81 | 3347 | 270 | 74 | 4.46 | 152.14 | |
145 | PPAR Research | journal | 1.091 Q1 | 59 | 31 | 139 | 1330 | 375 | 133 | 2.76 | 42.90 | |
146 | European Journal of Medicinal Chemistry | journal | 1.079 Q1 | 203 | 894 | 1992 | 41666 | 8168 | 1991 | 3.87 | 46.61 | |
147 | Life Sciences | journal | 1.074 Q1 | 191 | 385 | 933 | 17353 | 2738 | 923 | 2.97 | 45.07 | |
148 | CNS and Neurological Disorders - Drug Targets | journal | 1.070 Q1 | 96 | 196 | 362 | 18231 | 990 | 313 | 2.50 | 93.02 | |
149 | International Immunopharmacology | journal | 1.061 Q1 | 149 | 381 | 929 | 16151 | 2877 | 911 | 2.83 | 42.39 | |
150 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.061 Q1 | 57 | 56 | 168 | 3331 | 457 | 163 | 2.55 | 59.48 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®